Latest Commercialization News

Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.

humm Group Limited has posted a statutory profit after tax of $13.9 million for the half-year ended 31 December 2025, marking a 49% decline from the previous year, driven by increased credit losses and legal costs. Despite challenges, the company declared a fully franked interim dividend of 1.5 cents per share.

Ionic Rare Earths is advancing its rare earth magnet recycling ambitions with strategic leadership relocation, government recognition, and new funding discussions. The company’s Belfast facility gains global significance as it targets key international markets.

Racura Oncology has developed a pioneering blood test that promises to fast-track key data on its cardioprotective drug RC220, potentially shaving two years off the clinical trial timeline. This innovation also enhances patient safety and recruitment prospects in the ongoing RAC-010 CPACS trial.

Brazilian Rare Earths has confirmed a breakthrough low-temperature acid-cure process achieving up to 97% rare earth extraction at just 150°C, promising lower costs and enhanced scalability for its Brazilian operations.

Rhythm Biosciences has taken a significant step toward commercialising its ColoSTAT blood test for colorectal cancer by enrolling the first physician in its Access Program, marking the transition from clinical trials to routine clinical use.

Critical Resources Limited has launched a six-month evaluation program in partnership with the South Dakota School of Mines & Technology to develop next-generation solid-state lithium-ion battery materials, aiming to reduce technical risks and accelerate prototype development.

BPM Minerals has raised A$3.5 million in a placement anchored by Terra Capital and Tribeca Investment Partners to accelerate exploration at its promising Forelands Gold Project in Western Australia.

BPM Minerals has secured the key Bonnie & Clyde tenement within its Forelands Gold Project, unlocking ground exploration and a maiden drilling program. A detailed geological review highlights promising Tropicana-style gold mineralisation potential, setting the stage for a major discovery in Western Australia’s Eastern Goldfields.

Grand Gulf Energy’s initial fieldwork at its Dry Wash Antimony Project in Utah reveals visible stibnite mineralisation, hinting at promising shallow deposits linked to nearby known mineral systems.

Noxopharm Limited has secured a major scientific milestone with the publication of its Sofra™ platform research in Nature Immunology, highlighting a novel anti-inflammatory mechanism with broad therapeutic potential.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.